In this study, we investigated the effect of spinach saponin-enriched lipophilic fraction (SSEF) on collagen (10 μg/mL)-stimulated platelet aggregation in vivo. Dietary SSEF dose-dependently inhibited collagen-induced platelet aggregation by decreasing thromboxane A2 production and intracellular Ca2+ agonist activity as an aggregation-inducing autacoidal molecule. In addition, SSEF significantly increased the formation of cyclic AMP and cyclic GMP, intracellular Ca2+ antagonists that are aggregation-inhibiting molecules in collagen-stimulated platelets. These results suggest that SSEF is a potent inhibitor of collagen-stimulated platelet aggregation in vivo. Prothrombin time and activated partial thromboplastin time, indicators of blood coagulation, were potently prolonged by dietary SSEF in vivo. These findings suggest that SSEF prolongs the interval time between the conversion of fibrinogen to fibrin. Dietary SSEF also inhibited 0.4 M sucrose-induced hemolysis. Accordingly, our data demonstrate that SSEF might be a useful tool for inhibiting platelet activation and blood coagulation in thrombotic diseases.
Get full access to this article
View all access options for this article.
References
1.
Prinz-LangenohlR, BronstrupA, ThorandB, HagesM, PietrzikK. Availability of food folate in humans. J Nutr, 1999; 129:913–916.
2.
EdwardsAJ, YouCS, SwansonJE, ParkerRS. A novel extrinsic reference method for assessing the vitamin A of plant foods. Am J Clin Nutr, 2001; 74:348–355.
3.
BergmanM, VarshavskyL, GottliebHE, GrosmanS. The antioxidant activity of aqueous spinach extract: chemical identification of activity fractions. Phytochemistry, 2001; 58:143–152.
4.
LomnitskiL, BergmanM, NyskaA, Ben-ShaulV, GrosmanS. Composition, efficacy, and safety of spinash extracts. Nutr Cancer, 2003; 46:222–231.
5.
SaniHA, RahatA, IsmailM, RosliR, EndriniS. Potential anticancer effect of red spinach (Amaranthus gangeticus) extract. Asia Pac J Clin Nutr, 2004; 13:396–400.
CattaneoM, TenconiPM, LecchiA, MannucciPM. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb Res, 1991; 62:717–724.
KaibuchiK, SanoK, HoshijimaM, TakaiY, NishizukaY. Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium, 1982; 3:323–335.
10.
MenshikovMY, IvanovaK, SchaeferM, DrummerC, GerzerR. Influence of the cGMP analog 8-PCPT-cGMP on agonist-induced increases in cytosolic ionized Ca2+ and on aggregation of human platelets. Eur J Pharmacol, 1993; 245:281–284.
11.
SanoY, SatoK, UchidaM, MurataM. Blood coagulation fibrinolysis of rats fed fish oil: reduced coagulation factors especially involved in intrinsic pathway and increased activity of plasminogen activator inhibitor. Biosic Biotechnol Biochem, 2003; 67:2100–2105.
FurieB, FurieBC. The molecular basis of blood coagulation. Cell, 1988; 53:505–518.
14.
AkoumA, JosefonviczJ, SigotM. Anticoagulant activity of a bacterial glycopeptide. Thromb Res, 1990; 60:9–18.
15.
ChoH-J, ChoiS-A, KinC-G, JungT-S, HongJ-W, RheeM-H, ParkH-J, ParkH-J. Spinach saponin-enriched fraction inhibits platelet aggregation in cAMP- and cGMP-dependent manner by decreasing TXA2, production, blood coagulation. Biomol Ther, 2011; 19:218–223.
16.
AfolayanAJ, JimohFO. Nutritional quality of some wild leafy vegetables in South Africa. Int J Food Sci Nutr, 2009; 60:424–431.
17.
TsaiYC, LinCL, ChenBH. Preparative chromatography of flavonoids and saponins in Gynostemma pentaphyllum and their antiploliferation effect on hepatoma cell. Phytomedicine, 2010; 18:2–10.
18.
MoonMK, AhnJY, KimS, RyuSY, KimYS, HaTY. Ethanol extract and saponin of Platycodon grandiflorum ameliorate scopolamine-induced amnesia in mice. J Med Food, 2010; 13:584–588.
19.
ChoHJ, HamHS, LeeTK, JungYJ, ChoiSA, KangHC, ParkHJ. Inhibitory effect of cordycepin on human platelet aggregation. J Biomed Lab Sci, 2004; 10:1–8.
20.
CharoIF, FeinmanRD, DetwilerTC. Interrelations of platelet aggregation and secretion. J Clin Invest, 1997; 60:866–873.
21.
HambergM, SvenssonJ, SamuelssonB. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A, 1975; 72:2994–2998.
WangRG, ZhuY, HalushkaPV, LincolnTM, MendelsohnME. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Acad Sci U S A, 1998; 95:4888–4893.
24.
StegmeierK, PillJ, Muller-BeckmannB, SchmidtFH, WitteEC, WolffHP, PatschekeH. The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug. Thromb Res, 1984; 35:379–395.
25.
GormanRR, JohnsonRA, SpilmanCH, AikenJW. Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3′-pyridinylmethyl)benzofuran-2-carboxylate. Prostaglandins, 1983; 26:325–342.
26.
DognéJM, de LevalX, HansonJ, FrederichM, LambermontB, GhuysenA, CasiniA, MasereelB, RuanKH, PirotteB, KolhP. New developments on thromboxane and prostacylcin modulators part I: thromboxane modulators. Curr Med Chem, 2004; 11:1223–1241.
27.
HansonJ, RolinS, ReynaudD, QiaoN, KelleyLP, ReidHM, ValentinF, TippinsJ, KinsellaBT, MasereelB, Pace-AsciakC, PirotteB, DognéJM. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist. J Pharmacol Exp Ther, 2005; 313:293–301.
28.
JangEK, AzzamJE, CickinsonNT, DavidsonMM, HaslamRJ. Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br J Haematol, 2002; 117:664–675.
SudoT, ItoH, KimuraY. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the antiplatelet drug, cilostazol, in platelets. Platelets, 2003; 14:381–390.
31.
SinhaAK, RaoAK, WillisJ, ColmanRW. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa. Proc Natl Acad Sci U S A, 1983; 80:6086–6090.
32.
PodolakI, GalanyA, SobolewskaD. Saponins as cytotoxic agents: a review. Phytochem Rev, 2010; 9:425–474.
33.
PriceKR, JohnsonIT, FenwickGR. The chemistry and biological significance of saponins in food and feedingstuffs. Crit Rev Food Sci Nutr, 1987; 26:27–135.
34.
BaumannE, StoyaG, VolknerA, RichterW, LemkeC, LinssW. Hemolysis of human erythrocytes with saponin affects the membrane structure. Acta Histochem, 2000; 102:21–35.
35.
WrightAJ, FinglasPM, SouthonS. Erythrocyte folate analysis: saponin added during lysis of whole blood can increase apparent folate concentrations, depending on hemolysate pH. Clin Chem, 2000; 46:1978–1986.
36.
SatoY, YamakoseH, SuzukiY. Mechanism of hypotonic hemolysis of human erythrocytes. Biol Pharm Bull, 1993; 16:506–512.
37.
FogariR, ZoppiA. Is the effect of antihypertensive drugs on platelet aggregatility and fibrinolysis clinical relevant?Am J Cardiovasc Drugs, 2005; 5:211–223.
38.
RobbinsIM, KawutSM, YungD, ReillyMP, LloydW, CunninghamG, LoscalzoJ, KimmelSE, ChristmanBW, BarstRJ. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur Respir J, 2006; 27:578–584.
